Loading...
4DMedical Limited
FDMDF•PNK
Healthcare
Medical - Devices
$0.16
$0.00(0.00%)
4DMedical Limited (FDMDF) Financial Performance & Income Statement Overview
Review 4DMedical Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
1230.44%
↑ 1230.44%
Operating Income Growth
10.16%
↑ 10.16%
Net Income Growth
-14.36%
↓ 14.36%
Operating Cash Flow Growth
-36.26%
↓ 36.26%
Operating Margin
-1284.50%
↓ 1284.50%
Gross Margin
-755.93%
↓ 755.93%
Net Profit Margin
-958.34%
↓ 958.34%
ROE
-44.40%
↓ 44.40%
ROIC
-49.14%
↓ 49.14%
4DMedical Limited (FDMDF) Income Statement & Financial Overview
Review 4DMedical Limited's (FDMDF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $2.96M | $792505.00 | $232713.00 | $116357.00 |
| Cost of Revenue | $186248.00 | $13.61M | $12.94M | $410.00 |
| Gross Profit | $2.78M | -$12.81M | -$12.71M | $115947.00 |
| Gross Profit Ratio | $0.94 | -$16.17 | -$54.61 | $1.00 |
| R&D Expenses | $1.59M | $2.07M | $340836.00 | $170418.00 |
| SG&A Expenses | $15.80M | $8.68M | $9.27M | $5.79M |
| Operating Expenses | $17.38M | $10.74M | $9.61M | $7.74M |
| Total Costs & Expenses | $17.57M | $24.35M | $22.55M | $7.74M |
| Interest Income | $205143.00 | $1.03M | $476335.00 | $168093.00 |
| Interest Expense | $69237.00 | $126770.00 | $140150.00 | $0.00 |
| Depreciation & Amortization | $158332.00 | $1.52M | $1.35M | $643040.00 |
| EBITDA | -$22.19M | -$16.75M | -$20.96M | -$10.51M |
| EBITDA Ratio | -$7.49 | -$27.81 | -$90.07 | -$90.37 |
| Operating Income | -$14.61M | -$23.56M | -$22.32M | -$11.16M |
| Operating Income Ratio | -$4.93 | -$29.72 | -$95.89 | -$95.89 |
| Other Income/Expenses (Net) | -$5.76M | $5.16M | $4.38M | $3.70M |
| Income Before Tax | -$20.37M | -$18.39M | -$17.94M | -$7.45M |
| Income Before Tax Ratio | -$6.88 | -$23.21 | -$77.07 | -$64.06 |
| Income Tax Expense | $2516.00 | -$2.79M | -$2.71M | $160537.00 |
| Net Income | -$20.37M | -$15.61M | -$15.23M | -$7.61M |
| Net Income Ratio | -$6.88 | -$19.69 | -$65.44 | -$65.44 |
| EPS | -$0.05 | -$0.04 | -$0.05 | -$0.02 |
| Diluted EPS | -$0.05 | -$0.04 | -$0.05 | -$0.02 |
| Weighted Avg Shares Outstanding | $410.39M | $371.58M | $305.82M | $329.51M |
| Weighted Avg Shares Outstanding (Diluted) | $410.39M | $371.58M | $305.82M | $329.51M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan